Table 1.
Cancer stem cells markers in solid tumors
| Cancer type | Phenotype | Model | References |
| Prostate cancer | CD44+ | PCa cell line and tumor xenograft in mice | [58] |
| Breast cancer | CD44+ CD24-/low | Patient-derived tumor xenograft in mice | [5] |
| Cervical cancer | CD44+ CD24+ | SiHa cell line | [55] |
| Gastric cancer | CD44+ CD24+ | AGS cell line and patient tissue samples | [56] |
| Nasopharyngeal carcinoma | CD24- | NPC cell lnes, mice | [54] |
| Gastric adenocarcinoma | CD44+ CD133+ | Patient tissue samples | [51] |
| Oral squamous cell carcinoma | CD44+ ALDH1 | Metastatic lymph nodes | [153] |
| Breast cancer | CD44v | Clinical samples | [154] |
| Prostate cancer | CD133 | Primary prostate cancer cell lines | [155] |
| Endometrial cancer | CD133 | Human endometrial cell lines | [42] |
| Liver cancer | CD133 | Huh-7 cells and tumor xenograft in mice | [47] |
| Prostate cancer | CD133 | Primary human prostate cancer cell lines | [155] |
| Cervical cancer | CD49f | SiHa and HeLa cell lines | [156] |
| Non-small cell lung cancer | CD49f | Patient-derived sphere-forming assays | [157] |
| Gastric cancer | CD49f | Gastric tumor tissues and tumor xenograft in mice | [75] |
| Colon cancer | CD49f | HT29 and Caco2 cell lines, clinical samples | [77] |
| Cervical cancer | ALDH | SiHa and HeLa cell lines, mice model | [85] |
| Colon cancer | ALDH1A3 | HT29 cell line | [158] |
| Colon cancer | ALDH1A1 | HT29 cell line and tumor xenograft in mice | [159] |
| Breast cancer | ALDH | Breast cancer tumor tissues | [160] |
CSCs: Cancer stem cells; ALDH: Aldehyde dehydrogenase; NPC: Nasopharyngeal carcinoma.